PATENT CLAIM ANALYSIS

Application Number: 16100593
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["435", "374000"]

Abstract:
The present invention relates to stem cells obtained from the amnion and their methods of obtaining and culturing. The present invention further relates to compositions comprising amnion-derived stem cells (ADSCs) and to methods of using ADSCs.

Claim (Index 3):
The method of  claim 1 , wherein the amniotic membrane tissue sample is cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.53846
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14660572', '12306871', '13581432', '13782968', '11205248']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6091186505222266
- 35 USC 102 Novelty (BERT): 0.6701583070250113
- Combined Prediction Score: 0.6152226161725051
- Mean Citation Score: 414.31510800000007
- Max Citation Score: 659.1192
- Similarity Product: 639.659699664402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test